Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 4/2019

01-06-2019 | Triage | CE-LETTER TO THE EDITOR

Intranasal sufentanil given in the emergency department triage zone for severe acute traumatic pain—a randomized double-blind controlled trail: comment

Authors: Simon-Pierre Corcostegui, Damien Commeau, Julien Galant, Fabien Ramon, Cédric Boutillier du Retail

Published in: Internal and Emergency Medicine | Issue 4/2019

Login to get access

Excerpt

Dear editor, …
Literature
1.
2.
Pasquier P, Dubost C, Boutonnet M et al (2014) Predeployment training for forward medicalisation in a combat zone: the specific policy of the French military health service. Injury 45:1307–1311CrossRefPubMed
3.
Service médical du RAID, Antenne médicale spécialisée de Satory (GIGN), Lapostolle F et al (2018) How should prehospital medical unit cope with mass shooting ? Ann Fr Med Urgence 8:316-325
4.
5.
Carli P, Pons F, Levraut J et al (2017) The French emergency medical services after the Paris and Nice terrorist attacks: what have we learnt ? Lancet 390:2735–2738CrossRefPubMed
Metadata
Title
Intranasal sufentanil given in the emergency department triage zone for severe acute traumatic pain—a randomized double-blind controlled trail: comment
Authors
Simon-Pierre Corcostegui
Damien Commeau
Julien Galant
Fabien Ramon
Cédric Boutillier du Retail
Publication date
01-06-2019
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 4/2019
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02069-5

Other articles of this Issue 4/2019

Internal and Emergency Medicine 4/2019 Go to the issue

CE - LETTER TO THE EDITOR

In-flight cardiac arrest and in-flight cardiopulmonary resuscitation during commercial air travel: consensus statement and supplementary treatment guideline from the German Society of Aerospace Medicine—comment

IM - CASE RECORD

A woman with abdominal pain, jaundice and elevated CA 19.9

IM - ORIGINAL

Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis

IM - COMMENTARY

Could hypoglycemia and hypoalbuminemia allow the identification of septic patients at high mortality risk in addition of clinical scores?

EM - ORIGINAL

Analysis of the early warning score to detect critical or high-risk patients in the prehospital setting

IM - COMMENTARY

Diuretic resistance in decompensated chronic heart failure: trying to get out of the “loop”
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits